3rd Circ. Denies GSK Rehearing Bid In Flonase Antitrust Suit

Law360 (February 7, 2018, 7:18 PM EST) -- The Third Circuit on Wednesday said it won’t reconsider its decision to let Louisiana sue GlaxoSmithKline for allegedly blocking a generic version of its nasal spray Flonase despite the state not actively opting out of a 2013 class action settlement.

The drugmaker had argued in January that a three-judge panel "devastated" the settlement process by requiring states to opt in while all other parties who wanted to bring their own suit had to opt out, and by taking away the idea that a settlement absolutely ended litigation...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.